All In MedTech

Device Trial Radar · NCT01018888

Safety and Efficacy Study of Artificial Cornea

Clinical Assessment of Auro KPro

Last checked: Nov 20, 2026Latest source record: Jan 8, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

20

Planned (sponsor's estimate)

Start

Aug 2010

Primary completion

Jun 2014

Study completion Jul 2014

Sponsor

Lead sponsor
AurolabAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 25, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 20 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the stability of artificial cornea manufactured by Aurolab and to assess its visual outcomes.

Conditions

  • Corneal Transplantation

Interventions

  • Auro KPro (Keratoprosthesis)Device

    Front plate with optical cylinder, a back plate and a titanium ring to hold the complex together

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Visual AcuityTime frame: 1st Month, 2nd Month, 3rd Month,5th Month, 7th Month, 9th Month and 12th Month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Aravind Eye Hospital

    Madurai, Tamil Nadu, India · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.